MIR6724-1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR6724-1 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR6724-1 data layer.

The strongest signal is observed in thymoma (THYM), where higher MIR6724-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6724-1 expression acts as an unfavorable survival marker.

THYM and ESCA are the cancer types where MIR6724-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
THYMOSTertileAll0.5440.889.0129view →
ESCAOSTertileII,III,IV0.3910.694.0359view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR6724-1–THYM (OS)

Kaplan–Meier survival curve for MIR6724-1 RNA-high vs -low samples in THYM.

Open the THYM breakdown →

Exploration